UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6001
WisdomTree Efficient Gold Plus Gold Miners Strategy Fund
GDMN
$181M
| $670K | ﹤0.01% |
9,256
+7,854
| +560% | +$738K |
2026 Q1
1 quarter
|
|
6002
Repay Holdings
RPAY
$365M
| $669K | ﹤0.01% |
159,354
-241,072
| -60% | -$838K |
2019 Q3
27 quarters
|
|
6003
IBEX
IBEX
$661M
| $669K | ﹤0.01% |
22,017
-41,732
| -65% | -$1.24M |
2022 Q4
14 quarters
|
|
6004
Gotham Enhanced 500 ETF
GSPY
$685M
| $667K | ﹤0.01% |
16,420
+13,164
| +404% | +$518K |
2023 Q4
10 quarters
|
|
6005
CALL
NovoCure
NVCR
$1.55B
| $667K | ﹤0.01% |
44,000
| – | – |
2026 Q1
1 quarter
|
|
6006
PUT
CoStar Group
CSGP
$12.3B
| $666K | ﹤0.01% |
23,500
+15,100
| +180% | +$519K |
2025 Q4
2 quarters
|
|
6007
Atlas Lithium Corp
ATLX
$49.4M
| $664K | ﹤0.01% |
179,996
+85,910
| +91% | +$383K |
2023 Q1
13 quarters
|
|
6008
Northern Trust Quality Dividend Defensive ETF
QDEF
$537M
| $664K | ﹤0.01% |
7,632
-373
| -5% | -$31.9K |
2016 Q1
41 quarters
|
|
6009
OneSpan
OSPN
$797M
| $663K | ﹤0.01% |
46,169
-63,763
| -58% | -$806K |
2014 Q4
46 quarters
|
|
6010
SIGA Technologies
SIGA
$223M
| $662K | ﹤0.01% |
181,998
+77,936
| +75% | +$349K |
2021 Q4
18 quarters
|
|
6011
Investar Holding Corp
ISTR
$383M
| $662K | ﹤0.01% |
22,110
+17,498
| +379% | +$500K |
2022 Q3
15 quarters
|
|
6012
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$181M
| $662K | ﹤0.01% |
17,131
+920
| +6% | +$36.1K |
2014 Q4
46 quarters
|
|
6013
Invesco BulletShares 2030 High Yield Corporate Bond ETF
BSJU
$326M
| $662K | ﹤0.01% |
25,645
+272
| +1% | +$7.02K |
2023 Q1
13 quarters
|
|
6014
So-Young International
SY
$206M
| $661K | ﹤0.01% |
446,553
+250,408
| +128% | +$602K |
2022 Q1
17 quarters
|
|
6015
Starz Entertainment Corp
STRZ
$425M
| $661K | ﹤0.01% |
22,890
+19,655
| +608% | +$428K |
2025 Q2
4 quarters
|
|
6016
NYLIM MacKay DefinedTerm Muni Opportunities Fund
MMD
$268M
| $658K | ﹤0.01% |
42,448
-8,006
| -16% | -$122K |
2014 Q4
46 quarters
|
|
6017
Bioventus
BVS
$727M
| $658K | ﹤0.01% |
69,683
+5,787
| +9% | +$55.3K |
2021 Q4
18 quarters
|
|
6018
BlackRock ETF Trust II iShares Short-Term California Muni Active ETF
CALI
$676M
| $657K | ﹤0.01% |
12,996
+12,978
| +72,100% | +$655K |
2025 Q4
2 quarters
|
|
6019
Bank of Marin Bancorp
BMRC
$462M
| $654K | ﹤0.01% |
23,622
-176,055
| -88% | -$4.59M |
2014 Q4
46 quarters
|
|
6020
Biomea Fusion
BMEA
$41.1M
| $654K | ﹤0.01% |
444,728
-70,827
| -14% | -$106K |
2021 Q3
19 quarters
|
|
6021
Pliant Therapeutics
PLRX
$50.1M
| $652K | ﹤0.01% |
571,760
-486,194
| -46% | -$592K |
2020 Q3
23 quarters
|
|
6022
ATN International
ATNI
$432M
| $651K | ﹤0.01% |
24,592
-7,047
| -22% | -$192K |
2016 Q2
40 quarters
|
|
6023
Titan Machinery
TITN
$521M
| $649K | ﹤0.01% |
30,713
-6,956
| -18% | -$143K |
2014 Q4
46 quarters
|
|
6024
Nu Skin
NUS
$200M
| $647K | ﹤0.01% |
122,629
-113,396
| -48% | -$725K |
2014 Q4
46 quarters
|
|
6025
Western Asset Intermediate Muni Fund
SBI
$103M
| $647K | ﹤0.01% |
82,174
+4,931
| +6% | +$38.3K |
2014 Q4
46 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.